4
Participants
Start Date
February 29, 2008
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Bevacizumab
10 mg/kg IV twice weekly on days 1 and 15.
Paclitaxel
60 mg/m\^2 IV weekly on days 1, 8, 15, and 22.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Genentech, Inc.
INDUSTRY
M.D. Anderson Cancer Center
OTHER